Answers are grounded in this paper and cite their sources.
Multiple myeloma (MM) is the second most common hematological malignancy and develops from a malignant plasma cell (PC) clone within the human bone marrow (BM). The proliferation and expansion of the malignant PC producing a monoclonal immunoglobulin eventually results in BM failure with anemia, skeletal involvement with osteolytic lesions and hypercalcemia, and renal failure due to the excessive production of paraprotein. 1
No takes yet. Share an insight, caveat, or question.
Yousef et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: